by ADRIAN MANZ | Aug 27, 2025 | The Doctor's Dose
Nvidia Earnings Beat Expectations, But Stock Falls Nvidia earnings beat expectations in the company’s latest quarterly report, but shares slipped in extended trading despite the upbeat results and guidance. The chipmaker continues to dominate the artificial...
by ADRIAN MANZ | Aug 27, 2025 | The Doctor's Dose
Snowflake Stock Jumps on Earnings: What Traders Need to Know Snowflake stock jumps on earnings after the cloud-based data platform delivered results that far exceeded Wall Street’s expectations. Shares surged more than 12% in after-hours trading as investors responded...
by ADRIAN MANZ | Aug 27, 2025 | The Doctor's Dose
Kohl’s Earnings Beat and Stock Surge: What Traders Should Watch Now A 20% pop puts Kohl’s earnings beat and stock surge in the spotlight, but leadership uncertainty and declining sales keep the turnaround thesis on trial. Date: August 27, 2025 • Ticker: KSS • Sector:...
by ADRIAN MANZ | Aug 26, 2025 | The Doctor's Dose
Nvidia Earnings: What Traders Should Watch and How AI’s Future Hangs on Cash Flow NVDA’s report is a referendum on the AI trade—watch China guidance, supply–demand balance, and hyperscaler capex. The catch: free cash flow across Big Tech is straining just as AI...
by ADRIAN MANZ | Aug 26, 2025 | The Doctor's Dose
Nvidia Earnings: A $4 Trillion AI Test for Wall Street Why Nvidia’s Earnings Matter Nvidia, the world’s most valuable public company, reports results today after the bell, and the stakes could not be higher. With a market capitalization of $4 trillion, Nvidia is not...
by ADRIAN MANZ | Aug 26, 2025 | The Doctor's Dose
India Holds Firm on Russian Oil as US Tariff Threats Loom Key Developments The Trump administration is preparing to impose punitive tariffs of up to 50% on Indian exports in response to New Delhi’s ongoing purchases of Russian crude oil. A planned US trade delegation...
by ADRIAN MANZ | Aug 26, 2025 | The Doctor's Dose
Eli Lilly’s Orforglipron Hits Target in Diabetes Trial—Oral GLP-1 Battle with Novo Nordisk Heats Up Key Takeaways 10.5% average weight loss in overweight/obese patients with Type 2 diabetes over ~72 weeks on orforglipron; GI side effects broadly in line with...
by ADRIAN MANZ | Aug 26, 2025 | The Doctor's Dose
Tesla Stock Rises: Why Day Traders Should Be Cautious After Gains Tesla stock rises again, notching its third straight day of gains and closing at $351.67—its highest since late May. The move follows a 6.2% surge on Friday after Fed Chair Jerome Powell’s Jackson Hole...
by ADRIAN MANZ | Aug 26, 2025 | The Doctor's Dose
Boeing Stock Pops as Korean Air Doubles Fleet: Why Jet Orders Are Soaring Boeing stock pops again as demand for new aircraft continues to accelerate. On Tuesday, shares of Boeing (BA) rose 3.5% to $234.83 after Korean Air announced a massive 103-plane order that...
by ADRIAN MANZ | Aug 26, 2025 | The Doctor's Dose
Stocks That Moved Today U.S. equities advanced after a dramatic policy headline—President Donald Trump said he fired Fed Governor Lisa Cook—rekindled questions about central bank independence. Beneath the noise, stocks that moved today were propelled by spectrum...
